Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Go back to Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
(NASDAQ: MBOT) Delayed: 1.85 --0 (-0%)
Previous Close $1.85    52 Week High
Open $1.85    52 Week Low
Day High $1.85    P/E N/A 
Day Low $1.85    EPS
Volume 20,639